Archive · 10 Jan 2026
Questions on Quality of Generic Drugs in India
A doctor named Dr. Cyriac Abby Philips did a study on generic medicines in India.
He tested 131 medicines and found that all of them met the quality standards set by the Indian government.
This is surprising because earlier reports showed that many medicines, especially from government stores, often failed quality tests.
The doctor's study suggests that the medicines are now better, but some people are asking questions about how the study was done.
They want to know if the tests were fair and if the medicines will work as well as the original, more expensive ones.
The government has rules to make sure medicines are good, but some people think these rules are not strict enough.
The doctor's study has started a big discussion about how to make sure all medicines in India are safe and effective.
Dr. Cyriac Abby Philips tested 131 generic drugs and found all passed quality standards.
Historical data shows significant quality issues with generic drugs, especially from government pharmacies.
The government has prosecuted 206 cases of poor-quality drugs from the Jan Aushadhi program between 2020 and 2025.
Questions raised about the study's methodology, including blinding, sample size, and procurement of reference samples.
Concerns about bioequivalence testing and batch-to-batch consistency in generic drugs.
- Who
- Dr. Cyriac Abby Philips and various government and private entities
- What
- A study on the quality of generic drugs in India, particularly those from government-funded pharmacies
- When
- The study was recently conducted and results were shared on social media; historical data from 2012, 2017, and 2024-2025 is referenced
- Where
- India, with a focus on government-funded pharmacies and the Jan Aushadhi program
- Why
- To assess the quality and reliability of generic drugs, especially those distributed through government schemes
- Study Conducted By
- Dr. Cyriac Abby Philips
- Number of Drugs Tested
- 131
- Pass Rate
- 100%
- Government Survey Failure Rate (2017)
- 10%
- Private Market Failure Rate (2017)
- 3.16%
- Jan Aushadhi Prosecutions (2020-2025)
- 206
- Himachal Pradesh Failures (2023-2025)
- 1,683
- Bioequivalence Mandate in India
- 2017